Background: Cell and molecular mechanisms mediating the cardiovascular effects of alcohol are not fully understood. Our aim was to determine the effect of moderate ethanol (EtOH) on sonic hedgehog (SHh) signaling in regulating possible stem cell antigen-1 positive (Sca1
PIDEMIOLOGIC AND LABORATORY investigations support an association between alcohol consumption and cardiovascular disease (CVD) (Klatsky, 2010; Liu et al., 2011; Morrow et al., 2010; Mukamal et al., 2010) that is a leading cause of death worldwide (Lozano et al., 2012) . In particular, regular light-moderate consumption of ethanol (EtOH) is recognized as a negative risk factor for CVD, but the cells targeted and signaling mechanisms involved are not fully understood.
Most of the problems associated with CVD are due to disease-related changes resulting in vessel remodeling and atherosclerosis that lead to arterial narrowing and blockage, resulting in heart attack or stroke. Vascular smooth muscle cells (vSMC) play a key role in the pathophysiology of arterial disease, yet the origins of vSMC contributing to the typically seen medial thickening and neointimal formation are still under debate (Tang et al., 2013) . Evidence put forth suggests that resident stem cells, present initially in low numbers within the vessel wall, become triggered to differentiate to vSMC and are active contributors to the remodeling and repair of the artery wall (Lin and Lue, 2013; Majesky et al., 2012; Tang et al., 2012) . This information highlights a putative new cell target to investigate for agents known to affect CVD (e.g., alcohol), as well as a potential novel therapeutic target for treatment of vascular disease. One resident stem cell population implicated in vascular disease is stem cell antigen-1 positive (Sca1 + ) adventitial progenitor cells (APC) (Hu et al., 2004; Klein et al., 2014; Torsney and Xu, 2011) . EtOH is known to regulate vSMC growth and migration (Hendrickson et al., 1998 Sayeed et al., 2002) , and we have previously reported that daily moderate alcohol consumption inhibits injury-induced vSMC hyperplasia and carotid remodeling in mice (Liu et al., 2011; Morrow et al., 2010) . However, the effect of EtOH on the functionality and regenerative capacity of resident vascular stem cells has yet to be ascertained.
In addition to its acknowledged involvement during embryological development, a role for sonic hedgehog (SHh) in adult vascular disease has been purported. The best characterized signaling mechanism involves SHh binding to its receptor patched 1 (Ptch1) resulting in the removal of its inhibitory effect on the smoothened receptor (SMO). SMO subsequently allows Gli family transcription factors to translocate to the nucleus and affect expression of SHh target genes, including Gli2 and Ptch1. This pathway can be blocked using cyclopamine (11-deoxojervine), which binds to SMO preventing it from signaling downstream . Increased SHh signaling has been demonstrated in vSMC responsible for restenotic lesions after vein grafting (Li et al., 2010) . Targeted local inhibition of the Ptch1 receptor in mouse carotid arteries in vivo attenuates vessel remodeling following injury (Redmond et al., 2013) , supporting a permissive role for recapitulated SHh signaling in this context. Moreover, EtOH has been reported to have significant modulatory effects on SHh signaling in the liver (Chan et al., 2014; Jung et al., 2008; Li et al., 2007) . The role of SHh in regulating vascular stem cell fate in vessel disease is not known. Of interest, Sca1 + APC reportedly colocalize in the healthy arterial vessel wall where SHh and its receptor Ptch1 are primarily expressed embryologically, that is, at the adventitial medial boundary (Passman et al., 2008) . The aim of our study was to determine any effect of EtOH on Sca1 + APC in vitro and during arterial remodeling in vivo, and to determine the role of SHh signaling in this response.
MATERIALS AND METHODS

Mouse Carotid Artery Partial Ligation
Carotid ligation was performed on Sca1-enhanced green fluorescent protein (eGFP) transgenic mice obtained from The Jackson Laboratory (Bar Harbor, ME); Stock #012643, strain name B6.Cg.Tg(Ly6a-EGFP)G5Dzk/j. These transgenic mice have an eGFP under the control of murine lymphocyte antigen 6 complex, locus A (Ly6a) promoter. Hemizygous Ly6a-GFP mice are viable, fertile, normal in size, and do not display any gross physical or behavioral abnormalities (Ma et al., 2002) . The eGFP transgene expression pattern corresponds to that of Sca1 (Ma et al., 2002) . The carotid artery ligation model of injury and remodeling were performed as described previously (Korshunov and Berk, 2003; Liu et al., 2011; Morrow et al., 2010) . All procedures were approved by the University of Rochester Animal Care Committee and conform to NIH guidelines (Guide for the Care and Use of Laboratory Animals). After buprenorphine analgesia (0.05 to 0.1 mg/kg SQ), and anesthesia using inhalational isoflurane, the mouse was positioned on a clean operating table, with a warming pad to maintain body temperature. The animal was clipped, and the surgical site prepped using betadine solution and alcohol. A midline cervical incision was made. With the aid of a dissecting microscope, the left external and internal carotid arterial branches were isolated and ligated with 6-0 silk suture reducing left carotid blood flow to flow via the patent occipital artery. The neck incision (2 layers, muscle and skin) was sutured closed. Partial ligation of the left carotid artery in this manner resulted in a decrease (~80%) in blood flow, leaving an intact endothelial monolayer. Buprenorphine was administered at least once postop 6 to 12 hours.
EtOH Treatment
For 1 week before ligation, mice received the equivalent of 2 drinks daily by oral gavage; that is, 0.8 g/kg of 200 proof EtOH (ASC/USP grade), giving a peak blood alcohol concentration (BAC) of 15 mM or 0.08%. For example, a 20 g mouse was gavaged with 18.75 ll EtOH in 200 ll water. This "daily moderate" alcohol feeding regimen was recontinued 1 day postligation, and continued daily for up to 2 weeks when animals were anesthetized and vessels harvested. The control group was gavaged with a calorically matched water-cornstarch mixture (Morrow et al., 2010) . There was no significant effect of EtOH consumption on mouse body weight over the experimental time frame, compared to the cornstarch control group (data not shown).
Cyclopamine Treatment
Sca1-eGFP mice were treated with the smoothened inhibitor, cyclopamine, or the vehicle 2-hydroxypropyl-b-cyclodextrin (HbCD) (Sigma-Aldrich, St. Louis, MO) alone as a control (essentially as described by van den Brink et al., 2001 ). Mice were injected (250 ll max volume) intraperitoneally (IP) 1 day before ligation, then every other day after ligation at a dose of 10 mg/kg cyclopamine (Sigma-Aldrich) dissolved in a solution of 45% (w/v) HbCD. There was no effect of cyclopamine treatment on mouse body weight, compared to the HbCD vehicle control group (data not shown).
Quantitative Real-Time RT-PCR
Total RNA (0.5 to 1 lg) isolated from whole carotids or from purified rat Sca1 + APC using Qiagen RNeasy Micro kit (Valencia, CA) was reverse-transcribed using iScriptTM cDNA Synthesis kit from BIO-RAD (Carlsbad, CA). The gene-specific oligonucleotide sequences were as previously described (Redmond et al., 2013; Sweeney et al., 2004) . GAPDH was used as a housekeeping gene. Real-time RT-PCR was performed using the Stratagene Mx3005 machine and the SYBER Ò Green Jumpstart PCR kit (SigmaAldrich) as described by the manufacturer.
Histomorphometry
On the indicated days postligation, mice were anesthetized (ketamine/xylazine) and perfusion fixed with 4% paraformaldehyde in sodium phosphate buffer (pH 7.0). Fixed carotids were embedded in paraffin for sectioning. Starting at the carotid bifurcation landmark (single lumen), a series of cross-sections (10 9 5 lm) were made, every 200 lm through 2 mm length of carotid artery. Cross-sections were deparaffinized, rehydrated in graded alcohols, and stained with Verhoeff-Van Gieson stain for elastic laminae and imaged using a Nikon TE300 microscope (Nikon Inc., Melville, NY) equipped with a Spot RT digital camera (Diagnostic Instruments, Sterling Heights, MI). Digitized images were analyzed using SPOT 5.2 Advanced imaging software (Diagnostic Instruments). Assuming a circular structure in vivo, the circumference of the lumen was used to calculate the lumen area, the intimal area was defined by the luminal surface and internal elastic lamina (IEL), the medial area was defined by the IEL and external elastic lamina (EEL), and the adventitial area was the area between the EEL and the outer edge, essentially as described previously (Korshunov and Berk, 2003; Liu et al., 2011; Morrow et al., 2010) .
Sca1
+ Cells In Vivo Sca1 + cells were identified as green fluorescence protein (eGFP)-expressing cells visualized in deparaffinized Sca1-eGFP mouse carotid cross-sections mounted with Sigma-Aldrich Fluoroshield with DAPI, using an FV1000 Olympus laser scanning confocal microscope (Waltham, MA). Numbers of eGFP-expressing cells in carotid cross-section images from different experimental groups were analyzed by Fiji ImageJ software (NIH, Bethesda, MD). "Analyze particles" function was used to count total cells (DAPI stained, blue) and eGFP (green) cells per section.
Immunohistochemistry
Carotid cross-sections were stained with rabbit polyclonal to alpha-smooth muscle actin (a-SMA) (Abcam ab5694, 1:200; Cambridge, MA); rabbit polyclonal Gli-2 antibody (Novousbio NBP2-23602SS, 1:50; Novus Biologicals, Littleton, CO); rabbit polyclonal Ptch1 antibody (Abcam, ab53715, 1:100), followed by a goat-anti-rabbit IgG secondary Alexa Fluor 594 Ò conjugate (Invitrogen Cat # A-11037; Waltham, MA). Isotype control and secondary antibody only control were performed. For antigen retrieval, slides were brought to a boil in 10 mM sodium citrate (pH 6.0) then maintained at a sub-boiling temperature for 10 minutes. Slides were cooled on the benchtop for 30 minutes then washed in deionized water 3 times for 5 minutes each before being washed in phosphate-buffered saline (PBS) for 5 minutes. The antigen retrieval protocol diminished endogenous eGFP transgene signal. Therefore, sections were costained with antieGFP antibody (1:1,000; Thermo Fisher, Waltham, MA) and donkey anti-mouse secondary Alexa Fluor 488 (1:2,000; Invitrogen). Numbers of Ptch1 or Gli2 expressing cells in whole carotid cross-sections from different experimental groups were analyzed by Fiji ImageJ software. "Analyze particles" function was used to count total cells (DAPI stained, blue) and the number of "red" cells per section.
Adventitial Sca1 + Cell Isolation and Purification
Rat thoracic aorta was harvested and placed in Hank's balanced salt solution with 1% fetal bovine serum (FBS). The endothelium was removed by scraping with a sterile scalpel blade before the adventitia was detached from the media following brief enzymatic digestion with 2.5 mg/ml collagenase (15 minutes at 37°C), using forceps under a dissection microscope, as described previously (Cappadona et al., 1999) . The adventitia was cut into 1 mm sections, placed in wells of 6-well plates and left to dry for 5 minutes. Minimum essential medium (EMEM) supplemented with 2 mM L-glutamine and 10% ATCC ESC qualified FBS (Manassas, VA) was added to each well and then plates left undisturbed for a minimum of 2 days in a cell culture incubator (37°C, 5% CO 2 ). Cells that migrated from the explanted tissue were dissociated and placed in EMEM media supplemented with 10% ATCC ESC qualified FBS and 2 mM L-glutamine. Dissociated cells were pelleted and treated in accordance with the EasySep Ò Sca1 Positive Selection Kit protocol from STEMCELL Technologies (STEMCELL Technologies, Cambridge, UK). The separated cells were analyzed for Sca1 purity by flow cytometry with IgG-PE cells used as control. Postpurification, Sca1 + APC were expanded and routinely repurified and eventually cloned using ClonaCell TM FLEX 03818 (STEM-CELL Technologies) according to the manufacturer's recommendations in order to maintain a pure Sca1 + population. Cells were routinely grown and expanded in maintenance medium III.
Sca1
+ APC Immunohistochemistry Cells were seeded onto UV-sterilized noncoated glass coverslips (20 mm) and grown for 24 hours, then fixed with 3.7% formaldehyde. Samples were permeabilized in 0.025% Triton X-100 PBS (15 minutes, RT), blocked using a 5% bovine serum albumin, 0.3 M glycine, 1% Tween PBS blocking solution (1 hour at room temperature), then incubated with anticalponin antibody (Cnn1, Sigma-Aldrich Cat No: C2687), antimyosin heavy chain antibody (Myh11, Abcam Cat No: ab683), or anti-Gli2 (Gli2, Abcam Cat No: ab167389) primary antibodies at the recommended dilutions at room temperature for 1 hour, or 4°C overnight. Samples were washed twice in PBS and incubated with the recommended concentration of appropriate secondary antibody in blocking buffer for 1 hour or 4°C overnight. Cell nuclei were stained using DAPI: PBS (dilution 1:1,000) at room temperature for 15 minutes. An Olympus CK30 microscope and FCell software (Olympus) were used to capture images. A threshold of background staining was defined using the secondary antibody control, and exposure rates were limited to rule out false positives. At least 5 images from the Olympus CK30 microscope per experimental group (minimum n = 4) were analyzed using ImageJ software, and confocal images were analyzed using Zen 2008 software (Zeiss Group, Irvine, CA).
Data Analysis
Four to six animals were used per experimental group. An analysis of variance test was performed on cell count data, and a Wilcoxon signed-rank test was used for comparison of 2 groups when compared to normalized control. Results are expressed as mean AE SEM. A value of p ≤ 0.05 was considered significant.
RESULTS
EtOH Attenuates Ligation Injury-Induced Carotid Remodeling in Sca1-eGFP Transgenic Mice
Partial ligation or sham operation was performed on the left carotid of Sca1-eGFP transgenic mice, treated with or without "daily moderate" EtOH by gavage. Carotids were harvested on day 14 postligation and morphologic analysis performed. Ligation injury resulted in increased adventitial and medial compartments and neointimal formation, resulting in a decreased lumen, when compared to the sham-operated group (Fig. 1) . Media and neo intima of the remodeled vessels were composed of alpha-actin-positive cells and Sca1 + cells, which did not appear to colocalize (Fig. 2) . EtOH treatment resulted in significantly reduced adventitia and neo intima, when compared to calorically matched ligated controls (Fig. 1) . Intimal-medial thickening was significantly reduced in the EtOH group, compared to ligated controls (Fig. 1) .
Daily Moderate EtOH Feeding Reduces Sca1 + Cell Expansion Following Ligation Injury
Cross-sections from paraformaldehyde fixed and paraffinembedded carotids from sham-operated and ligated mice, treated with or without EtOH, were evaluated by confocal microscopy for cells with eGFP fluorescence, indicative of Sca1 expression. In sham-operated carotids, there was a small number of eGFP-expressing cells present in the adventitia and at the lumen lining of the vessel (Fig. 3 ). There were markedly increased numbers of eGFP-expressing cells (i.e., Sca1 + ) in the vessel wall postligation (day 14), particularly in the media and neo intima (Fig. 3) . Daily EtOH treatment attenuated vessel remodeling (Fig. 3A) concomitant with a reduction in Sca1 + cells (assessed as a percentage of total cells) (Fig. 3A,C) .
EtOH Reduces SHh Signaling in Ligation-Injured Mouse Carotids
To determine the effect of daily moderate EtOH treatment on SHh signaling in mouse carotids, immunohistochemistry for SHh target genes Ptch1 and Gli2 was performed in crosssections from sham-operated, ligated, and ligated + EtOH experimental groups. Immunohistochemistry data show that both Ptch1 and Gli2 expression were markedly increased in ligated vessels compared to sham-operated vessels, especially in the neo intima and media, and that some cells expressing these target genes colocalized with Sca1(eGFP)-expressing cells (Figs 4 and 5A) . EtOH treatment attenuated both Ptch1 and Gli2 expression in ligated vessels (Figs 4 and 5A) . Moreover, whole-vessel Gli2 mRNA levels were significantly reduced in ligated vessels from wild-type C57BL/6 mice treated with EtOH, compared to no-alcohol controls (Fig. 5B) . Together, these data indicate that EtOH inhibits ligation injury-induced SHh signaling in mouse carotids.
Cyclopamine Reduces Ptch1 Expression, Inhibits Sca1 + Cell Expansion, and Attenuates Injury-Induced Vessel Remodeling
Carotid ligation was performed in Sca1-eGFP mice treated with the SHh signaling inhibitor cyclopamine (10 mg/kg, IP, every other day) or the vehicle control HbCD. Expression of the SHh target gene Ptch1, determined by immunohistochemistry, in ligated carotid cross-sections was decreased by cyclopamine treatment (Fig. 6) . Similar to EtOH, cyclopamine treatment significantly reduced the amount of Sca1 + cells found in vessels postligation, compared to control ligated vessels; 42 AE 3% versus 65 AE 5% (percent of total number of cells), n = 5. Moreover, vessel remodeling was attenuated in the cyclopamine-treated group; carotid intimal-media ratio was significantly less in cyclopamine-treated mice compared to ligated controls; 11 AE 3.5% versus 58 AE 1.73% (intima/media ratio) (Fig. 7) .
EtOH Inhibits SHh-Induced Myogenic Differentiation of Sca1 + APC In Vitro
Treatment of purified and cloned rat Sca1 + APC in vitro with rSHh (0.5 lg/ml) stimulated Gli2 target gene mRNA levels and promoted myogenic differentiation to smooth Fig. 2 . Smooth muscle cell a-actin expression in stem cell antigen-1 (Sca1)-enhanced green fluorescent protein (eGFP) transgenic mice carotid cross-sections from sham-operated (Sham), ligated (cornstarch), and ligated treated with ethanol (Ligated + EtOH) groups. Immunohistochemistry for smooth muscle-specific a-actin was performed on sections from vessels harvested 14 days postligation or sham operation, using an anti-alpha-smooth muscle actin (a-SMA) antibody (Abcam ab5694). Representative images shown; blue = Dapi nuclear stain, Green = eGFP (i.e., Sca1 + ), red = a-actin. 920 magnification on left (scale bars 50 lM); 960, of boxed portion, shown on right. Width of Adventitia "A" denoted by yellow line, media: "M" white line, neo intima: "NI" red line.
ALCOHOL REGULATES VASCULAR SCA1
+ STEM CELLSmuscle cells as mRNA for the smooth muscle-specific markers myosin heavy chain 11 (Myh11) and calponin (Cnn1) were both significantly increased (Fig. 8A) . Treatment of cells with rSHh also increased the fraction expressing Cnn1 as determined by immunocytochemistry (Fig. 8B ). These effects were markedly attenuated by EtOH treatment (25 mM), similar to the effect of the SHh inhibitor cyclopamine (15 lM) (Fig. 8) . These experiments were repeated in murine Sca1 + C3H10T1/2 stem cells, with quantitatively similar results (data not shown). These data indicate that
Sca1
+ progenitor stem cells are SHh responsive and that EtOH inhibits SHh-induced myogenic differentiation of Sca1 + progenitor cells.
DISCUSSION
We report that EtOH feeding inhibits SHh-stimulated Sca1 + progenitor cell expansion and attenuates carotid remodeling in ligation-injured Sca1-eGFP transgenic mice. This novel effect of EtOH on vascular stem cells may contribute, in part, to the cardiovascular protective effects of moderate alcohol consumption.
Numerous epidemiological studies have investigated the relationship between imbibing alcohol and general overall health. With respect to CVD specifically, meta-analysis reveals that compared with abstinence, regular light-to-moderate consumption of alcohol is associated with the lowest risk for CVD incidence and mortality (Bagnardi et al., 2008; Corrao et al., 2000; Roerecke and Rehm, 2014; Ronksley et al., 2011) . "Light-to-moderate" alcohol consumption is generally considered to be in the range of 1 to 3 drinks/d, giving rise to blood alcohol levels (BAC) of approximately 5 to 25 mM. Conversely, episodic binge drinking (i.e., 5 or more drinks in <2 hours) or chronic excessive alcohol use resulting in BAC up to 50 mM are associated with a higher incidence of cardiovascular disorders and increased mortality (Ruidavets et al., 2010; Thun et al., 1997) . In apparent agreement with such epidemiologic findings, we have previously reported differential effects, beneficial and deleterious, respectively, of "daily moderate" versus "2-day binge" alcohol feeding on arteriosclerosis in a mouse model (Liu et al., 2011) .
Under certain conditions, atherosclerotic plaques develop following interactions between circulating inflammatory cells, lipids, and the cells (i.e., endothelial cells, smooth muscle cells, adventitial fibroblasts) comprising the artery wall. Ultimately, hyperplasia of vSMC in the media and their accumulation in the tunica intima plays a key role in wall thickening seen in atherosclerosis and in restenosis following stenting (Doran et al., 2008) . The classic hypothesis was that quiescent contractile medial vSMC switch to a synthetic phenotype capable of proliferation and translocation. Moreover, there is often significant adventitial remodeling in response to vessel injury and adventitial myofibroblasts are believed capable of translocating to the neo intima and differentiating to vSMC and in this way also contribute to vascular lesion formation (Scott et al., 1996; Shi et al., 1996) . In addition to alcohol effects on lipoproteins (Hao et al., 2015; Wakabayashi, 2015) , we and others have described potentially important effects of alcohol on vSMC growth and migration (Cahill and Redmond, 2012; Cullen et al., 2005; Sayeed et al., 2002; Shirpoor et al., 2013) , as well as on vascular endothelial cells (Morrow et al., 2008) and monocytes (Cullen et al., 2005; Muralidharan et al., 2014) . The emergence of the concept that resident vascular stem cells, in addition to dedifferentiation of vSMC and myofibroblasts as mentioned above, may become activated and contribute to arterial pathology (Orlandi, 2015) , together with the lack of information as to whether alcohol can regulate stem cells in the adult vessel, provoked our present study.
Sca1 is a candidate marker used in the search for tissueresident stem cells (Holmes and Stanford, 2007) , and it is recognized as an antigen of adult vascular wall-resident stem cells (Hu et al., 2004; Orlandi, 2015; Torsney and Xu, 2011) . Our data show Sca1 + cells are present, albeit sparsely, in healthy mouse carotids, in the adventitia and lining the lumen. The Sca1 + cells lining the lumen stained positively for endothelial nitric oxide synthase (data not shown) and were negative for a-SMA. Of note, vascular endothelial cells reportedly express Sca1 (Holmes and Stanford, 2007; Kotton et al., 2003) , and they can display plasticity in disease. Recently, endothelial cells were shown to undergo transformation (i.e., endothelial-mesenchymal transition) to smooth muscle-like cells that contribute to neointimal formation reviewed in Lao et al., 2015) . This may also be the case in our study, but it will require further investigation for a definitive answer. + APC in maintenance media were treated in vitro with or without rShH (0.5 lg/ml), in the absence or presence of EtOH (25 mM), or cyclopamine (15 lM), for 7 days before mRNA levels of the SHh target gene Gli2, and smooth muscle-specific markers myosin heavy chain 11 (Myh11) and calponin (Cnn1) were assessed by RT-PCR. Data are from a representative experiment of 3 with similar results. (B) rSHh treatment of rat Sca1 + APC cells increased the fraction expressing Cnn1 as determined by immunocytochemistry, an effect markedly attenuated by either EtOH (25 mM), or cyclopamine (15 lM). Representative images shown, together with cumulative data showing fraction of Cnn1 + cells in each experimental group. Mean AE SEM, n = 3.
After ligation injury, there was a marked expansion of the Sca1 + cell population in remodeled vessels, especially in the neointimal compartment, but also in the media and adventitia. In contrast, in carotids of mice that were ligated but received alcohol, there were significantly less Sca1 + cells in vessel cross-sections, concomitant with attenuated vessel remodeling (i.e., reduced adventitial enlargement and less neo intima formation). These data suggest that alcohol feeding attenuates neointimal thickening by inhibiting resident Sca1 + progenitor cell expansion. Of note, reduced neointimal thickening in moderate EtOH consumers would be expected to result in less atherosclerotic plaque and, thus, reduced vascular occlusive events leading to fewer heart attacks and strokes.
The precise source of the Sca1 + cell population that accumulates within the medial and intimal layers following injury is unknown. Sca1 expression has been identified on putative stem/progenitor cell populations within numerous tissues (Holmes and Stanford, 2007) . Whether these Sca1 + cell populations are truly tissue-specific precursor/stem cells or represent hematopoietic, mesenchymal, or endothelial precursor/ stem cells associated with these tissues is not known in all cases. Sca1 + progenitor cells could potentially arise locally or be recruited from the circulation in response to injury. However, a recent study using wild-type and c-myb h/h mice lethally irradiated and reconstituted with eGFP + bone marrow indicated that >99% of all carotid adventitial CD45 À Lin À Sca1 + cells were host vessel-derived (Shikatani et al., 2016) . Several potential stem/progenitor cell populations have been identified as residing in the intima, media, and adventitia including Sca1 + CD45 + adventitial macrophage progenitor cells (Psaltis et al., 2014) and Sca1 + CD45 À progenitor cells that give rise to endothelial and mesenchymal cell lineages (Naito et al., 2012; Tigges et al., 2013) . Although our study does not fully clarify the relative contribution of APC to vessel remodeling, it clearly identifies the expansion of a Sca1 + /a-SMA negative progenitor cell population within the media and intima in response to vessel injury. Moreover, the accumulation of this population, irrespective of its source, is subject to significant inhibition following treatment with EtOH. Additional lineage tracing experiments of Sca1 + cells using transgenic mice will help definitively identify Sca1 + progeny following ligation injury AE EtOH; this strategy has been successful in distinguishing a contribution of Sca1-derived cells to cardiomyocytes during normal aging and following ischemic damage and pressure overload (Uchida et al., 2013) .
We, and others, have implicated the SHh pathway in vessel disease pathogenesis. SHh signaling regulates vSMC growth in vitro Morrow et al., 2007 Morrow et al., , 2009 Walshe et al., 2011) and in vivo (Li et al., 2010; Morrow et al., 2007 Morrow et al., , 2009 Passman et al., 2008; Walshe et al., 2011) . Components of the SHh pathway are induced after vascular injury (Morrow et al., 2009 ) and during vein graft intimal hyperplasia (Li et al., 2010) , and inhibition of SHh signaling using Ptch1 siRNA applied locally at the site of ligation injury attenuates intimal-medial thickening (Redmond et al., 2013) . Moreover, a role for SHh in stem cell regulation and maintenance in other contexts has been described (Huang and Kalderon, 2014; Mooney et al., 2015; Siggins et al., 2009 + cell expansion and remodeling of injured mouse carotids, to an extent similar to the EtOH treatment groups.
In conclusion, these data indicate that daily moderate alcohol consumption attenuates pathologic arterial remodeling by inhibiting SHh-dependent expansion of Sca1 + vascular stem cells. Further, these data highlight resident progenitor cells as additional vascular "targets" for alcohol. Targeting of these progenitor stem cells represents a novel mechanism whereby beneficial alcohol consumption patterns may lessen vessel neointimal lesions and, thus, CVD.
